Curative Labs Inc.

1700 Royston Ln, Suite B

Round Rock, TX 78664
support@curative.com
Final Results Report

Patient Name: Moreno, Maritza Facility: Texas Curative Testing

Patient MRN: CUR139604587 Requisition: 44500779

Date of Birth: 1956-10-10 (64 years old) Kit ID: 711246060861

Sex: female Collected: 08/09/21 09:29:57 AM CDT

Address: 1360 W County Line Rd New Braunfels, TX 78130 Received: 08/10/21 08:57:03 AM CDT

Phone
12103185615 Released: 08/10/21 09:26:01 PM CDT
Number:

Specimen
Email: maritzamoreno1010@yahoo.com Alinity shallow nasal swab
Type:

Physician: Zalzala, Sajad (1639311509) Reviewed By: Cecilia Hoyle

Test Result

SARS-CoV-2 Assay (RNA Detection Test by RT-qPCR) Positive

Interpretation:

Positive: SARS-CoV-2 RNA detected by RT-qPCR

Negative: SARS-CoV-2 RNA not detected by RT-qPCR
Indeterminate: Indeterminate for SARS-CoV-2 RNA by RT-qPCR.

Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is
necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent
detected may not be the definite cause of disease. Laboratories within the United States and its territories are required to report all positive results to
the appropriate public health authorities.

Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Inadequate sample
collection or exposure to extreme heat during transport may decrease the ability to detect SARS-CoV-2 RNA in a sample. Negative results must be
combined with clinical observations, patient history, and epidemiological information.

Indeterminate results may occur in the case of an inadequate specimen such as quantity not sufficient. Specimen must be recollected if test is still
required.

Method: Real-Time Reverse-Transcription PCR

This test is based on the CDC SARS-CoV-2 assay, a real-time reverse-transcription polymerase chain reaction (RT-PCR) test that detects RNA from
SARS-CoV-2 in upper or lower respiratory specimens. The test has been optimized to be performed on the BioRad CFX Real-Time PCR detection
system.

Disclaimer:

This SARS-CoV-2 PCR test was developed and its performance characteristics were determined by Curative Labs. This test has not been cleared,
approved or authorized by the U.S. Food and Drug Administration (FDA). This test may be used for clinical purposes and should not be regarded as
investigational or for research only. Curative Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as
qualified to perform high complexity clinical laboratory testing. The results are not intended to be used as the sole means for clinical diagnosis or
patient management decisions.

Lab director: Arthur Baca, MD PhD; CLIA # 45D2192800; Report generated at: 08/10/21 09:47:34 PM CDT